Revolutionary allergy care to free the world from allergies
Employees: 11-50
Total raised: $16.5M
Investors 1
| Date | Name | Website |
| - | Gold House... | goldhouse.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.12.2022 | Series A | $16.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 29.08.2023 | Nectar Opens First Brick-and-Mortar Allergy Clinic in NYC | What You Should Know: Nectar Life Sciences, the trusted health technology company behind the first hybrid, vertically-integrated allergy care platform, today announced the grand opening of its flagship Nectar Allergy Center, located in New ... |
| 22.12.2022 | USA-based Nectar raises USD 16.5 million in Series A | New York, USA-based innovative and comprehensive allergy care platform, Nectar raised USD 16.5 million in Series A funding. The round took place on December 20, 2022. Harmony Partners led the financing for the firm. Meanwhile, founding part... |
| 20.12.2022 | Nectar raises $16.5M to personalize allergy treatments | The company will use the funding to build out its first physical locations across the country While most people likely think of allergies as an annoyance, they are an expensive problem, resulting in $245 billion in annual direct medical cos... |
| 20.12.2022 | Nectar Raises Over $16.5M in Series A Funding | Nectar, a New York-based provider of an allergy care platform, raised $16.5m in Series A funding. The round, which brought total equity raised to over $24m, was led by Harmony Partners, with participation from Juxtapose and Obvious Ventures... |